generation MEK inhibitor

Related by string. * generations . GENERATION . Generations . GENERATIONS : Next Generation Networks . baby boomer generation . Baby Boom generation . Baby Boomer generation / mek . Mek . MeK : methyl ethyl ketone MEK . Raf MEK ERK . RAS RAF MEK ERK . MEK ERK / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . ACE inhibitors * *

Related by context. Frequent words. (Click for all words.) 58 PXD# 56 RDEA# 55 Phase 1b 54 Phase 2a clinical 54 BCX# 53 multiple ascending dose 53 Phase III Trial 53 HspE7 53 Phase 2a trial 53 Phase 2a 53 Completes Enrollment 52 Initiates Phase 52 Phase Ib 52 Atiprimod 52 IMGN# 52 phase 2a 51 orally bioavailable 51 phase IIb 51 Phase 2b study 51 MGCD# [001] 51 sapacitabine 50 PRX # 50 Phase 2b 50 drug conjugate 50 dose escalation trial 50 ISIS # 50 Clinical Study 50 TELCYTA 50 AP# [003] 50 Phase IIa 50 OXi# 50 Zerenex 50 Biologics License Application 49 MDV# 49 TG# [001] 49 INCB# [002] 49 ADXS# 49 Phase 2b trial 49 confirmatory Phase 3 49 Synavive 49 MOZOBIL 49 HGS ETR1 48 single ascending dose 48 Phase IIa trial 48 Phenoptin 48 PRX# 48 VEGF Trap 48 CYC# 48 Phase IIb 48 PEG Interferon lambda 48 Phase IIb clinical 48 confirmatory Phase III 48 Phase IIa clinical 48 HuMax CD# 48 eculizumab 48 ofatumumab 48 perifosine 48 tesetaxel 48 phase IIa 47 Phase 2b clinical 47 RG# [001] 47 Phase III 47 Phase 1b clinical 47 humanized monoclonal antibody 47 NGX# 47 randomized Phase III 47 laquinimod 47 kinase inhibitor 47 Restanza 47 tgAAC# 47 IDX# 47 Amigal 47 XL# [003] 47 Phase III pivotal 47 CF# [002] 46 T DM1 46 PF # [001] 46 dose cohorts 46 pivotal Phase 46 follicular non 46 GRN#L 46 Phase IIb trial 46 PS# [001] 46 IND enabling 46 CRx 46 ZYBRESTAT 46 Phase III clinical 46 Phase 46 dose escalation 46 MLN# 46 dose escalation study 46 alogliptin 45 DURATION 45 pivotal Phase III 45 Investigational Device Exemption IDE 45 Cisplatin 45 unblinded 45 label dose escalation 45 pegloticase 45 preclinical 45 methylnaltrexone

Back to home page